NCT00841230已完成4 期
Additional Value of Deanxit in Tinnitus Patients Treated With Rivotril
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- Visual Analogue Scale
研究概览
简要总结
The purpose of this study is to investigate whether increased tinnitus reduction can be obtained with Deanxit in patients already receiving Rivotril.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •pure tone, narrow band noise or polyphonic tinnitus
- •unilateral or bilateral tinnitus
- •cochleair origin tinnitus
- •tinnitus present 3 months or more
- •age 18y or more
- •intake Rivotril 1mg/d
- •patient 'able to cooperate'
- •patient able to fill in TQ en VAS
- •No pontine angle pathology on MRI
排除标准
- •pulsatile tinnitus
- •pregnancy or breast feeding
- •contra-indications Deanxit
- •recovery myocard infarct
- •conduction disorder His
- •untreated glaucoma
- •MAO inhibitors: 15d stop
- •otosclerosis
- •middle ear pathologies
- •somatic tinnitus
研究组 & 干预措施
Lactose placebo
Placebo Comparator
1x/day
干预措施: Lactose placebo (Drug)
Deanxit
Experimental
干预措施: Deanxit (Drug)
结局指标
主要结局
Visual Analogue Scale
时间窗: 3 weeks, 6 weeks
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
The Effect of Tinnitus Retraining Therapy on Subjective and Objective Measures of Chronic TinnitusTinnitusNCT00124800Tinnitus Research Consortium41
已完成
3 期
A Trial of Magnesium Dependent TinnitusTinnitusNCT01273883Mayo Clinic38
Enrolling By Invitation
不适用
Tinnitus and Cochlear ImplantsTinnitusNCT06085885University of Nottingham50
已完成
不适用
1 Tinnitus Alleviation Via Sensory SubstitutionTinnitusNCT02570048MuteButton60
已完成
不适用
A trial of the Oticon Tinnitus Sound Support feature in hearing aids for adults with hearing loss and tinnitus.TinnitusHearing loss (deafness)Ear - Other ear disordersEar - DeafnessACTRN12621001754831The University of Auckland40